Notwithstanding, we previously determined soluble levels of MIF in BCC patients and a different RG, and we found a decreased concentration of MIF in BCC patients (Guevara‐Gutiérrez et al., 2021). This evidence concerns the gene MIF and skin basal cell carcinoma.